Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3699382011 | Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3700161018 | Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3759887016 | Product containing precisely fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation pressurized conventional release suspension for inhalation (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4512191000052115 | flutikasonpropionat 125 mikrogram/dos och salmeterol (som salmeterolxinafoat) 25 mikrogram/dos, inhalationssprej, suspension | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Has presentation strength denominator unit (attribute) | Actuation (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | räkning av bas i aktiv ingrediens | 2 (qualifier value) | false | Inferred relationship | Some | ||
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Is a | Product containing fluticasone and salmeterol (medicinal product) | false | Inferred relationship | Some | ||
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Has unit of presentation | Actuation (unit of presentation) | true | Inferred relationship | Some | ||
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Has manufactured dose form | Pressurized conventional release suspension for inhalation (dose form) | true | Inferred relationship | Some | ||
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Is a | Product manufactured as pulmonary dose form (product) | false | Inferred relationship | Some | ||
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Has presentation strength denominator unit (attribute) | Actuation (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 2 | |
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Has precise active ingredient | Salmeterol xinafoate | true | Inferred relationship | Some | 1 | |
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Has basis of strength substance (attribute) | Salmeterol (substance) | true | Inferred relationship | Some | 1 | |
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | har täljarvärde som visar styrka | 25 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | har täljarvärde som visar styrka | 125 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Has basis of strength substance (attribute) | Fluticasone propionate (substance) | true | Inferred relationship | Some | 2 | |
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Has precise active ingredient | Fluticasone propionate (substance) | true | Inferred relationship | Some | 2 | |
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Is a | Fluticasone and salmeterol only product in pulmonary dose form | true | Inferred relationship | Some | ||
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Is a | Product containing glucocorticoid (product) | false | Inferred relationship | Some | ||
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Is a | Product containing beta-2 adrenergic receptor agonist (product) | false | Inferred relationship | Some | ||
| Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | Is a | Phenol structure-containing product | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR